These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3644589)

  • 1. Detection of HTLV-III/LAV-specific IgG and antigen in bronchoalveolar lavage fluid from two patients with lymphocytic interstitial pneumonitis associated with AIDS-related complex.
    Resnick L; Pitchenik AE; Fisher E; Croney R
    Am J Med; 1987 Mar; 82(3):553-6. PubMed ID: 3644589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocytic interstitial pneumopathy in AIDS-related complex. Presence of the LAV virus in the bronchoalveolar lavage fluid].
    Ziza JM; Brun Vezinet F; Venet A; Traversat J; Raphael M; Langlois P; Piette JC; Chapelon C; Herson S; Godeau P
    Presse Med; 1986 Jul 5-12; 15(27):1267-9. PubMed ID: 2945180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAV/HTLV-III infection in children of African origin: experience in Belgium.
    Jonckheer T; Levy J; Van de Perre P; Thiry L; Henrivaux P; Sacré JP; Schepens G; Mees N; Dab I; Taelman H
    Eur J Pediatr; 1986 Dec; 145(6):511-6. PubMed ID: 2949977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
    Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
    Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
    McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
    Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrathecal and intrathecal IgG response to the AIDS virus LAV/HTLV-III in experimental infection of chimpanzees.
    Goudsmit J; Gibbs CJ; Asher DM; Gajdusek DC
    Cancer Detect Prev Suppl; 1987; 1():509-14. PubMed ID: 3480064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic alterations in bronchoalveolar lavage fluid in the acquired immunodeficiency syndrome (AIDS).
    Rankin JA; Walzer PD; Dwyer JM; Schrader CE; Enriquez RE; Merrill WW
    Am Rev Respir Dis; 1983 Jul; 128(1):189-94. PubMed ID: 6307101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of HTLV-III/LAV antigens in peripheral blood lymphocytes from patients with AIDS.
    Pekovic DD; Chausseau JP; Lapointe N; Michaud J; Garzon S; Strykowski H; Tsoukas C; Gilmore N; Goldman H; Gornitsky M
    Arch Virol; 1986; 91(1-2):11-9. PubMed ID: 3092784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease.
    Daniele RP; Elias JA; Epstein PE; Rossman MD
    Ann Intern Med; 1985 Jan; 102(1):93-108. PubMed ID: 3881071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma, HTLV-III/LAV, and HTLV-III/LAV antibody in the wife of a man with transfusion-acquired AIDS.
    Duncan ED; Miller HJ; McKeever WP
    Am J Med; 1986 Nov; 81(5):898-900. PubMed ID: 3640579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV).
    Harada S; Purtilo DT; Koyanagi Y; Sonnabend J; Yamamoto N
    J Immunol Methods; 1986 Sep; 92(2):177-81. PubMed ID: 3639115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interstitial lymphoid pneumonia and polyadenopathies in patients infected with the LAV/HTLV III virus].
    Couderc LJ; Hervé P; Solal-Celigny P; Herman D; D'Agay MF; Morinet F; Matheron S; Rabian C; Caubarrere I; Clauvel JP
    Presse Med; 1986 Jun; 15(24):1127-30. PubMed ID: 2942907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases.
    Lawrence EC; Martin RR; Blaese RM; Teague RB; Awe RJ; Wilson RK; Deaton WJ; Bloom K; Greenberg SD; Stevens PM
    N Engl J Med; 1980 May; 302(21):1186-8. PubMed ID: 7366658
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
    Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
    Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic nature of a Pol gene product of HTLV-III/LAV.
    Allan JS; Coligan JE; Lee TH; Barin F; Kanki PJ; M'Boup S; McLane MF; Groopman JE; Essex M
    Blood; 1987 Jan; 69(1):331-3. PubMed ID: 3024760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal Langerhans cells--a target for HTLV-III/LAV infection.
    Tschachler E; Groh V; Popovic M; Mann DL; Konrad K; Safai B; Eron L; diMarzo Veronese F; Wolff K; Stingl G
    J Invest Dermatol; 1987 Feb; 88(2):233-7. PubMed ID: 3100656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanavalin A dependent cell-mediated cytotoxicity (CDCMC) in bronchoalveolar lavage (BAL) fluid of patients with interstitial lung diseases (ILD). Evidence of cytolytic T-lymphocyte (CTL) activity.
    Norin A; Karpel J; Fleitman J; Kamholz S; Pinsker K
    Chest; 1986 Mar; 89(3 Suppl):144S-145S. PubMed ID: 3948576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.